{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:38:24Z","timestamp":1784893104804,"version":"3.55.0"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ijbiomac.2021.08.197","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:48:09Z","timestamp":1630532889000},"page":"44-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["The role of amyloids in Alzheimer's and Parkinson's diseases"],"prefix":"10.1016","volume":"190","author":[{"given":"Parveen","family":"Salahuddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munazza Tamkeen","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan Hasan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyaul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Furkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0959-440X(92)90169-8","article-title":"Unfolded proteins, compact states and molten globule","volume":"2","author":"Dobson","year":"1992","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/358302a0","article-title":"The folding of hen lysozyme involves partially structured intermediates and multiple pathways","volume":"358","author":"Radford","year":"1992","journal-title":"Nature"},{"issue":"362","key":"10.1016\/j.ijbiomac.2021.08.197_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/362553a0","article-title":"Human lysozyme gene mutations cause hereditary systemic amyloidosis","volume":"1993","author":"Pepys","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/385787a0","article-title":"Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis","volume":"385","author":"Booth","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2741\/4204","article-title":"The triple power of D3: protein intrinsic disorder in degenerative diseases","volume":"19","author":"Uversky","year":"2014","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u00df oligomer and Alzheimer\u2019s disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0035","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1002\/anie.200906670","article-title":"Amyloidogenic protein-membrane interactions: mechanistic insight from model systems","volume":"49","author":"Butterfield","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/alzrt203","article-title":"On the subject of rigor in the study of amyloid \u00df-protein assembly","volume":"5","author":"Teplow","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0045","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nsmb1345","article-title":"Evidence of fibril-like \u00df-sheet structures in a neurotoxic amyloid intermediate of Alzheimer\u2019s \u00df-amyloid","volume":"14","author":"Chimon","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.1799","article-title":"Structural conversion of neurotoxic amyloid-beta(1\u201342) oligomers to fibrils","volume":"17","author":"Ahmed","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2016.02.065","article-title":"Structure of amyloid oligomers and their mechanisms of toxicities: targeting amyloid oligomers using novel therapeutic approaches","volume":"114","author":"Salahuddin","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0060","doi-asserted-by":"crossref","first-page":"27300","DOI":"10.1074\/jbc.M114.569004","article-title":"Antiparallel triple-strand architecture for prefibrillar A\u00df42 oligomers","volume":"289","author":"Gu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature02940","article-title":"Addendum: pathways towards and away from Alzheimer's disease","volume":"431","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archneurol.2007.56","article-title":"Protein misfolding and neurodegeneration","volume":"65","author":"Soto","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0075","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate A\u00df and Alzheimer's disease\u2013like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat. Med."},{"issue":"2010","key":"10.1016\/j.ijbiomac.2021.08.197_bb0080","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"GCG remodels mature a-synuclein and amyloid-\u00df fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.2008.02068.x","article-title":"The emerging concept of functional amyloid","volume":"265","author":"Maury","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2016.02.037","article-title":"Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease","volume":"1647","author":"March","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1006\/jmbi.2000.3908","article-title":"The protofilament substructure of amyloid fibrils","volume":"300","author":"Serpell","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jsbi.1995.1024","article-title":"Architecture and polymorphism of fibrillarsupramolecular assemblies produced by in vitro aggregation of human calcitonin","volume":"115","author":"Bauer","year":"1995","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0105","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jmb.2005.03.022","article-title":"Higher-order molecular packing in amyloid-like fibrils constructed with linear arrangements of hydrophobic and hydrogen-bonding side-chains","volume":"348","author":"Saiki","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0110","first-page":"240146","article-title":"Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems","author":"Cacciatore","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0115","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer\u2019s disease in the United States and the public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0120","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.410340527","article-title":"The apolipoprotein epsilon 4 allele in patients with Alzheimer\u2019s disease","volume":"34","author":"Mayeux","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0125","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS","volume":"50","author":"Mahley","year":"2009","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.08.197_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and alzheimer disease: risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0135","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"APOE and Alzheimer Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0145","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1083\/jcb.100.6.1905","article-title":"Subunit structure of paired helical filaments in Alzheimer\u2019s disease","volume":"100","author":"Wischik","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0150","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1073\/pnas.88.6.2288","article-title":"Straight and paired helical filaments in alzheimer disease have a common structural unit","volume":"88","author":"Crowther","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.1064638","article-title":"A portrait of alzheimer secretases\u2013new features and familiar faces","volume":"293","author":"Esler","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nn940","article-title":"Alzheimer\u2019s disease: treatments in discovery and development","volume":"5","author":"Citron","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0165","doi-asserted-by":"crossref","first-page":"1131?1147","DOI":"10.2174\/138161212799315786","article-title":"Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions","volume":"18","author":"Kitazawa","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.08.197_bb0170","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1212\/WNL.54.11.2045","article-title":"The molecular and genetic basis of AD: the end of the beginning: the 2000 wartenberg lecture","volume":"54","author":"Rosenberg","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","article-title":"Protein misfolding, evolution and disease","volume":"24","author":"Dobson","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0180","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0185","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0022-2836(92)90835-8","article-title":"Beyreuther, substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer\u2019s disease beta A4 peptides","volume":"228","author":"Hilbich","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000259044","article-title":"Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological options","volume":"85","author":"Tillement","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0195","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1038\/399a023","article-title":"Translating cell biology into therapeutic advances in Alzheimer\u2019s disease","volume":"399","author":"Selkoe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0200","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1021\/cr040410w","article-title":"Copper homeostasis and neurodegenerative disorders (Alzheimer\u2019s, prion, and Parkinson\u2019s diseases and amyotrophic lateral sclerosis)","volume":"106","author":"Gaggelli","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0205","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1074\/jbc.270.7.3063","article-title":"The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation","volume":"270","author":"Soto","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.1993.tb23043.x","article-title":"Lansbury, the C-terminus of the beta protein is critical in amyloidogenesis","volume":"695","author":"Jarrett","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0215","doi-asserted-by":"crossref","first-page":"9907","DOI":"10.1073\/pnas.160086297","article-title":"Designed protein tetramer zipped together with a hydrophobic alzheimer homology: a structural clue to amyloid assembly","volume":"97","author":"Otzen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nsb752","article-title":"Kinetic partitioning of protein folding and aggregation","volume":"9","author":"Chiti","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0225","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0022-2836(02)00399-6","article-title":"Mutations that reduce aggregation of the Alzheimer\u2019s Abeta42 peptide: an unbiased search for the sequence determinants of abeta amyloidogenesis","volume":"319","author":"Wurth","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0230","doi-asserted-by":"crossref","first-page":"16419","DOI":"10.1073\/pnas.212527999","article-title":"Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases","volume":"99","author":"Chiti","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0065-3233(08)60320-4","article-title":"The structure of amyloid fibrils by electron microscopy and X-ray diffraction","volume":"50","author":"Sunde","year":"1997","journal-title":"Adv. Protein. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0245","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1006\/jmbi.2000.3908","article-title":"The protofilament substructure of amyloid fibrils","volume":"300","author":"Serpell","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jsbi.1995.1024","article-title":"Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin","volume":"115","author":"Bauer","year":"1995","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0255","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jmb.2005.03.022","article-title":"Higher-order molecular packing in amyloid-like fibrils constructed with linear arrangements of hydrophobic and hydrogen-bonding side-chains","volume":"348","author":"Saiki","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0260","unstructured":"A.T. Petkova Y. Ishii M.J. Balbach O.N. Antzutkin R.D. Leapman F. Delaglio R. Tycko A structural model for Alzheimer's beta amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0265","doi-asserted-by":"crossref","first-page":"21891","DOI":"10.1016\/S0021-9258(17)31886-0","article-title":"Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide","volume":"269","author":"Lepoivre","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0270","first-page":"12787","article-title":"An overview of APP processing enzymes and products","volume":"29","author":"Chow","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jsbi.2000.4259","article-title":"Studies on the in vitro assembly of ab 1e40: implications for the search for ab fibril formation inhibitors","volume":"130","author":"Goldsbury","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0280","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid b-protein fibrillogenesis","volume":"274","author":"Walsh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0285","doi-asserted-by":"crossref","first-page":"19232","DOI":"10.1073\/pnas.0703793104","article-title":"Directed selection of a conformational antibody domain thatprevents mature amyloid fibril formation by stabilizing Ab protofibrils","volume":"104","author":"Habicht","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0290","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/anie.201007265","article-title":"Solid-state NMR spectroscopic investigation of ab protofibrils: implication of a b-sheet remodeling upon maturation into terminal amyloid fibrils","volume":"50","author":"Scheidt","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0295","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease:amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0300","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0305","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-2836(03)00927-6","article-title":"Mixtures of wildtype and a pathogenic (E22G) form of Ab40 in vitro accumulate protofibrils, including amyloid pores","volume":"332","author":"Lashuel","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0310","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1002\/anie.200906670","article-title":"Amyloidogenic proteinemembrane interactions: mechanistic insight from model systems","volume":"49","author":"Butterfield","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0315","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nsmb.2266","article-title":"High-resolution structure of infectious prion protein: the final frontier","volume":"19","author":"Diaz-Espinoza","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0320","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0065-3233(06)73008-X","article-title":"Structural models of amyloid-like fibrils","volume":"73","author":"Nelson","year":"2006","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0325","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/ar300282r","article-title":"Molecular structures of amyloid and prion fibrils: consensus versus controversy","volume":"46","author":"Tycko","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0330","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0335","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1074\/jbc.M409507200","article-title":"Alzheimer's Abeta40 studied by NMR at low pH reveals that sodium 4,4dimethyl-4-silapentane-1-sulfonate (DSS) binds and promotes beta-ball oligomerization","volume":"280","author":"Laurents","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0340","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/bi802046n","article-title":"Structural characterization of a soluble amyloid beta-peptide oligomer","volume":"48","author":"Yu","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0345","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/jmbi.2000.3559","article-title":"Structural studies of soluble oligomers of the alzheimer beta-amyloid peptide","volume":"297","author":"Huang","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0355","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1073\/pnas.0408582102","article-title":"Structural properties of abeta protofibrils stabilized by a small molecule","volume":"102","author":"Williams","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0360","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsb.2006.02.013","article-title":"High resolution scanning tunnelling microscopy of the beta-amyloid protein (Abeta1-40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly","volume":"155","author":"Losic","year":"2006","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0365","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure-neurotoxicity relationships of amyloid beta-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc. Natl. Acad. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0370","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediatesized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0375","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from alphasynuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0380","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0385","unstructured":"Mitsubishi Chemical Corp European Patent WO0017184 2000."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0390","unstructured":"Mitsubishi Chemical Corp European Patent WO0018758 2000."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0395","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-140036","article-title":"Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AbPP(L\/S) transgenic mice","volume":"42","author":"Nguyen","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.08.197_bb0400","doi-asserted-by":"crossref","first-page":"2129e2134","DOI":"10.1021\/bm0701402","article-title":"Inhibition of alzheimer amyloid aggregation with sulfated glycopolymers","volume":"8","author":"Miura","year":"2007","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.08.197_bb0405","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/jvi.67.2.643-650.1993","article-title":"Sulfated polyanion inhibition ofscrapie-associated PrP accumulation in cultured cells","volume":"67","author":"Caughey","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0410","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1213151","article-title":"Atomic view of a toxic amyloid small oligomer","volume":"335","author":"Laganowsky","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0415","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1021\/jacs.5b09536","article-title":"Amyloid \u00df-protein C-terminal fragments: formation of cylindrins and \u00df-barrels","volume":"138","author":"Do","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0420","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","article-title":"Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties","volume":"295","author":"Tenidis","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0425","first-page":"6","article-title":"Atomic structures of fibrillar segments of hIAPP suggest tightly mated \u00df-sheets are important for cytotoxicity","volume":"3","author":"Krotee","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0430","doi-asserted-by":"crossref","first-page":"13472","DOI":"10.1021\/ja054039l","article-title":"Capturing intermediate structures of Alzheimer's betaamyloid, Abeta(1\u201340), by solid-state NMR spectroscopy","volume":"127","author":"Chimon","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0435","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00232-003-0638-7","article-title":"Architecture of the Alzheimer's a beta P ion channel pore","volume":"197","author":"Arispe","year":"2004","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0440","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1073\/pnas.0502066102","article-title":"Amyloid ion channels: a common structural link for protein misfolding disease","volume":"102","author":"Quist","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0445","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1529\/biophysj.107.110148","article-title":"Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process","volume":"93","author":"Jang","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0450","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.3233\/JAD-2012-129001","article-title":"Molecular mechanisms of amyloid oligomers toxicity","volume":"33","author":"Kayed","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0455","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1074\/jbc.275.19.14077","article-title":"Alzheimer's beta -amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line","volume":"275","author":"Kawahara","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00232-004-0709-4","article-title":"Amyloid peptide channels","volume":"202","author":"Kagan","year":"2004","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0465","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0196-9781(02)00067-0","article-title":"The channel hypothesis of Alzheimer's disease: current status","volume":"23","author":"Kagan","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0470","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/JMN:11:3:183","article-title":"Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses","volume":"11","author":"Yatin","year":"1998","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0475","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1073\/pnas.90.16.7789","article-title":"Tau protein kinase I is essential for amyloid beta protein-induced neurotoxicity","volume":"90","author":"Takashima","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0480","first-page":"304","article-title":"Membrane incorporation, channel formation, and disruption of calcium homeostasis by Alzheimer's b-amyloid protein","volume":"12","author":"Kawahara","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0485","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayersis a common conformation dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0490","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1074\/jbc.M808591200","article-title":"Annular protofibrils are a structurally and functionally distinct type of amyloidoligomer","volume":"284","author":"Kayed","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0495","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neurobiolaging.2004.02.010","article-title":"Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease","volume":"25","author":"Klein","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0500","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0505","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/0929866043407174","article-title":"Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration","volume":"11","author":"Walsh","year":"2004","journal-title":"Protein. Pept. Lett."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0510","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers","volume":"280","author":"Demuro","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0515","doi-asserted-by":"crossref","first-page":"10971","DOI":"10.1021\/bi034889i","article-title":"The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies","volume":"42","author":"Porat","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0520","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1529\/biophysj.106.089482","article-title":"Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers","volume":"91","author":"Canale","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0525","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0033583506004422","article-title":"Are amyloid diseases caused by protein aggregates that mimic bacterial poreforming toxins?","volume":"39","author":"Lashuel","year":"2006","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0530","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0535","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1529\/biophysj.108.130997","article-title":"Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity","volume":"95","author":"Valincius","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0540","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jmb.2004.07.052","volume":"342","author":"Green","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0545","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1085\/jgp.200609533","article-title":"Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure","volume":"128","author":"Sokolov","year":"2006","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0550","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1667\/0033-7587(2000)154[0171:SSOMPB]2.0.CO;2","article-title":"Surfactant sealing of membranes permeabilized by ionizing radiation","volume":"154","author":"Hannig","year":"2000","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0555","series-title":"Alzheimer's Disease","author":"Kayed","year":"2013"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0560","doi-asserted-by":"crossref","first-page":"31374","DOI":"10.1074\/jbc.M400348200","article-title":"Prefibrillar amyloid protein aggregates share common features of cytotoxicity","volume":"279","author":"Bucciantini","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0565","series-title":"Neurodegenerative Diseases as Protein Folding Disorders","first-page":"243","article-title":"The molecular and cellular basis of neurodegenerative diseases underlying mechanisms","author":"Jeremy","year":"2018"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0570","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0575","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1074\/jbc.M606202200","article-title":"A ganglioside-induced toxic soluble abeta assembly. its enhanced formation from abeta bearing the Arctic mutation","volume":"282","author":"Yamamoto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0580","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jnr.21998","article-title":"NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus","volume":"87","author":"Yamin","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0585","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/JMN:17:2:137","article-title":"Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease","volume":"17","author":"Glabe","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0590","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0595","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","article-title":"Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease","volume":"119","author":"Gouras","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0600","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2559.2001.01082.x","article-title":"Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease","volume":"38","author":"D'Andrea","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0605","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1083\/jcb.141.4.1031","article-title":"Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture","volume":"141","author":"Skovronsky","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0610","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.nbd.2005.02.008","article-title":"Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses","volume":"20","author":"Almeida","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0615","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","article-title":"Massive CA1\/2 neuronal loss with intraneuronal and N terminal truncated Abeta42 accumulation in a novel alzheimer transgenic model","volume":"165","author":"Casas","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0620","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/B:NEUR.0000044197.83514.64","article-title":"Dendrite and dendritic spine alterations in alzheimermodels","volume":"33","author":"Moolman","year":"2004","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0625","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/13506120208995241","article-title":"Intraneuronal Abeta42 accumulation in down syndromebrain","volume":"9","author":"Mori","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0630","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0635","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0640","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1523\/JNEUROSCI.1879-05.2005","article-title":"Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy","volume":"25","author":"Spires","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0645","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","article-title":"Intraneuronal alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology","volume":"161","author":"Takahashi","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0650","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","article-title":"Betaamyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system","volume":"26","author":"Almeida","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0655","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.mad.2005.07.006","article-title":"Amyloid peptide attenuates the proteasome activity in neuronal cells","volume":"126","author":"Oh","year":"2005","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0660","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","article-title":"Abeta inhibits the proteasome and enhances amyloid and tau accumulation","volume":"29","author":"Tseng","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0665","first-page":"214","article-title":"Bcl-2: beclin 1 complex: multiple, mechanisms regulating autophagy\/apoptosis toggle switch","volume":"2","author":"Marquez","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0670","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/jsbi.2000.4274","article-title":"Review: Alzheimer's amyloid b-peptide-associated free radical oxidative stress and neurotoxicity","volume":"130","author":"Varadarajan","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0675","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.freeradbiomed.2007.05.037","article-title":"Roles of amyloid b-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment","volume":"43","author":"Butterfield","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0680","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neurobiolaging.2008.07.003","article-title":"Evidence that Gama-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease","volume":"31","author":"Jo","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0685","unstructured":"L. Zheng K. K\u00e5gedal N. Dehvari E. Benedikz R. Cowburn J. Marcusson A. Terman Oxidative stress induces macroautophagy of amyloid b-pro."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0690","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson's disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0695","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0700","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fneur.2019.00391","article-title":"Beta amyloid deposition is not associated with cognitive impairment in Parkinson's disease","volume":"10","author":"Melzer","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0705","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0710","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes parkinson and lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0715","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0720","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0725","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0730","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to earlyonset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0735","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0740","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0745","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","article-title":"Accelerated oligomerization by Parkinson\u2019s disease linked alpha-synuclein mutants","volume":"920","author":"Conway","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0750","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(98)01419-7","article-title":"Effects of the mutations Ala30 to pro and Ala53 to thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson\u2019s disease","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0755","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0760","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson\u2019s disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0765","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0770","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0161-813X(02)00066-9","article-title":"Conformational behavior of human alpha-synuclein is modulated by familial Parkinson\u2019s disease point mutations A30P and A53T","volume":"23","author":"Li","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0775","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46 K mutation in alpha-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0780","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0785","doi-asserted-by":"crossref","first-page":"45996","DOI":"10.1074\/jbc.M106777200","article-title":"Residual structure and dynamics in Parkinson\u2019s disease-associated mutants of alpha-synuclein","volume":"276","author":"Bussell","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0790","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review","volume":"30","author":"Petrou","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0795","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00415-018-9100-8","article-title":"Amyloid-\u00df and Parkinson\u2019s disease","volume":"266","author":"Lim","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0800","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1389203721666200204122732","article-title":"Process, outcomes and possible elimination of aggregation with special reference to heme proteins; likely remediations of proteinopathies","volume":"21","author":"Furkan","year":"2020","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0805","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijbiomac.2019.05.152","article-title":"An antibiotic (sulfamethoxazole) stabilizes polypeptide (human serum albumin) even under extreme condition (elevated temperature)","volume":"135","author":"Furkan","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0810","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ijbiomac.2019.02.107","article-title":"An in vitro elucidation of the antiaggregatory potential of diosminover thermally induced unfolding of hen egg white lysozyme; a preventive quest for lysozyme amyloidosis","volume":"129","author":"Furkan","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.08.197_bb0815","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human a-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0820","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0825","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of a-synuclein determined by cryo-electron microscopy","volume":"28","author":"Yaowang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0830","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1073\/pnas.1013225108","article-title":"Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation","volume":"108","author":"Giehm","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0835","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/092986611794578332","article-title":"UverskyCharacterization of the non-fibrillar alpha-synuclein oligomers","volume":"18","author":"Hong","year":"2011","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0840","doi-asserted-by":"crossref","first-page":"63?71","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of alpha-synuclein oligomers: characterization by Raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0845","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molbrainres.2004.09.001","article-title":"Pathogenic effects of alpha-synuclein aggregation","volume":"134","author":"Lundvig","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0850","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/iub.316","article-title":"Oligomeric alpha-synuclein and its role in neuronal death","volume":"62","author":"Brown","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0855","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","article-title":"Alpha-synuclein: membrane interactions and toxicity in Parkinson's disease","volume":"26","author":"Auluck","year":"2010","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0860","article-title":"Membrane permeabilization by oligomeric alpha-synuclein: in search of the mechanism","volume":"5","author":"vanRooijen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0865","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/138920310791330659","article-title":"Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease","volume":"11","author":"van Rooijen","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0870","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0875","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0880","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2004.10.010","article-title":"The role of alpha-synuclein in neurodegenerative diseases","volume":"105","author":"Bennett","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0885","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-4159.2004.02423.x","article-title":"Could a loss of alpha-synuclein function put dopaminergic neurons at risk?","volume":"89","author":"Perez","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0890","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.expneurol.2006.03.011","article-title":"Hero versus antihero: the multiple roles of alpha-synuclein in neurodegeneration","volume":"199","author":"Cookson","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0895","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson\u2019s disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0900","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson's disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0905","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.10487","article-title":"Genetic and environmental factors in the cause of Parkinson\u2019s disease","volume":"53","author":"Warner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0910","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.wco.0000186841.43505.e6","article-title":"How genetics research in Parkinson\u2019s disease is enhancing understanding of the common idiopathic forms of the disease","volume":"18","author":"Cookson","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0915","first-page":"415","article-title":"A common LRRK2 mutation in idiopathic Parkinson\u2019s disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0920","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/mds.27199","article-title":"Cognitive impairment in gluco- cerebrosidase (GBA)-associated PD: not primarily associated with cerebrospinal fluid abeta and tau profiles","volume":"32","author":"Lerche","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0925","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and dementia in GBA- associated Parkinson\u2019s disease: the mutation matters","volume":"80","author":"Cilia","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0930","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/mds.27731","article-title":"Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile","volume":"34","author":"Lerche","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0935","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson's disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0940","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","article-title":"Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for lewy-body formation in Parkinson disease","volume":"7","author":"Chung","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0945","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0950","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinson\u2019s Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0955","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1089\/ars.2015.6313","article-title":"Mitochondria: the cellular hub of the dynamic coordinated network","volume":"22","author":"Yin","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0960","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jtbi.1999.1046","article-title":"Accumulation of defective mitochondria through delayed degradation of damaged organelles and its possible role in the ageing of post-mitotic and dividing cells","volume":"202","author":"Kowald","year":"2000","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0965","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0970","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.02.003","article-title":"The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway","volume":"30","author":"Ferreiro","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0975","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","article-title":"Oxidative stress in alzheimer disease: a possibility for prevention","volume":"59","author":"Bonda","year":"2010","journal-title":"Neuropharma-cology"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0980","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.0022-3042.2001.00681.x","article-title":"\u00df-amyloid inhibits integrated mitochondrial respiration and key enzyme activities","volume":"80","author":"Casley","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0985","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.freeradbiomed.2008.02.017","article-title":"Gender and age- dependent differences in the mitochondrial apoptogenic pathway in Alzheimer\u2019s disease","volume":"44","author":"Lloret","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0990","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease","volume":"131","author":"Shoshan-Barmatz","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb0995","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1113\/jphysiol.2002.035196","article-title":"Mitochondrial Ca2 uptake pre- vents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals","volume":"548","author":"David","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1000","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/159160","article-title":"Mitochondrial contribution to Parkinson\u2019s disease pathogenesis","author":"Schapira","year":"2011","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1005","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"333","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1010","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/301812","article-title":"Mitochondrial dys-function in idiopathic Parkinson disease","volume":"62","author":"Parker","year":"1998","journal-title":"Am. J. Hum. Genetics"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1385\/JMN:18:3:229","article-title":"Mutant and wild-type a-synuclein interact with mitochondrial cytochrome C oxidase","volume":"18","author":"Elkon","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1020","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of a-synuclein impair complex I in human dopaminergic neuronal cultures and parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1025","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1030","first-page":"410","article-title":"Genetic screening for a single common LRRK2 mutation in familial Parkinson\u2019s disease","volume":"365","author":"Nichols","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1040","first-page":"415","article-title":"A com- Mon LRRK2 mutation in idiopathic Parkinson\u2019s disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/prca.201600005","article-title":"Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration","volume":"10","author":"Stauch","year":"2016","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","article-title":"PINK1-associ- ated Parkinson\u2019s disease is caused by neuronal vulnerability to calcium-induced cell death","volume":"33","author":"Gandhi","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1055","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s11064-008-9729-2","article-title":"Mitochondrial respiratory dysfunction in familiar parkinsonism associated with PINK1 mutation","volume":"33","author":"Piccoli","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/cdd.2016.104","article-title":"Deficiency of Parkinson\u2019s disease-related gene Fbxo7 is associated with impaired Mito- chondrial metabolism by PARP activation","volume":"24","author":"Delgado-Camprubi","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jnc.13024","article-title":"Lipid peroxidation is essential for a-synuclein-induced cell death","volume":"133","author":"Angelova","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1070","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/ars.2010.3849","article-title":"Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease","volume":"16","author":"Thomas","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2017.08.044","article-title":"Mitochondrial calcium imbalance in Parkinson's disease","volume":"663","author":"Ludtmann","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/ars.2010.3849","article-title":"Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease","volume":"16","author":"Thomas","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1085","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3233\/JAD-161118","article-title":"Therapeutics of neurotransmitters in Alzheimer's disease","volume":"57","author":"Kandimalla","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121837","article-title":"Lipophilic triphenylphosphonium cations inhibit mitochondrial electron transport chain and induce mitochondrial proton leak","volume":"10","author":"Trnka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mcn.2019.03.001","article-title":"Small molecules as therapeutic drugs for Alzheimer's disease","volume":"96","author":"Oliver","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1100","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1105","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.2174\/138161210793292519","article-title":"Mitochondria-targeted antioxidant peptides","volume":"16","author":"Rocha","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.115396","article-title":"Anti-tuberculotic thionamide antibiotics show antioxidative and neuronal cytoprotective nature by inhibiting amyloid formation in human insulin and amyloid \u00df-42","volume":"326","author":"Khan","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2021.08.197_bb1120","doi-asserted-by":"crossref","first-page":"16742","DOI":"10.1073\/pnas.262663499","article-title":"A structural model for Alzheimer's \u03b2-amyloid fibrils based on experimental constraints from solid state NMR","volume":"99","author":"Petkova","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021018729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021018729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:55:16Z","timestamp":1758876916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021018729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":223,"alternative-id":["S0141813021018729"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.08.197","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of amyloids in Alzheimer's and Parkinson's diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.08.197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}